Rapid HPLC method for the simultaneous monitoring of duloxetine, venlaflaxine, fluoxetine and paroxetine in biofluids

Bioanalysis

Volumn 1, Issue 5, 2009, Pages 905-917

  Samanidou, Victoria F ^a   Kourti, Paraskevi V ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXANOL DERIVATIVE; DULOXETINE; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; THIOPHENE DERIVATIVE; VENLAFAXINE;

ARTICLE; BLOOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSTRUMENTATION; LIMIT OF DETECTION; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; URINE; VALIDATION STUDY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOHEXANOLS; FLUOXETINE; HUMANS; LIMIT OF DETECTION; PAROXETINE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEROTONIN UPTAKE INHIBITORS; THIOPHENES;

EID: 79951791843     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.09.78     Document Type: Article

References (53)

1. Nash J, Nutt D. Psychopharmacology of anxiety. Psychiatry 6, 143-148 (2007).
2. Papakostas GI, Thase ME, Fava M, Nelson JC, Shelton RC. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta ana lysis of studies of newer agents. Biol. Psychiatry 62, 1217-1227 (2007).
3. Stahl MS, Entsuah R, Rudolf LR. Comparative effcacy between VEN and SSRIs: a pooled ana lysis of patients with depression. Biol. Psychiatry 52, 1166-1174 (2002).
4. Mc Manus P, Mant A, Mitchell PB, Montogomery WS, Marley J, Auland ME. Recent trends in the use of antidepressant drugs in Australia, 1990-1998. Med. J. Aust. 173, 458-461 (2000).
5. Laux G, Baumann P, Hiemke C. Therapeutic drug monitoring of antidepressants-clinical aspects. J. Neural Transm. Suppl. 72, 261-267 (2007).
6. Keller B, Hirschfeld A, Demyttenaere K, Baldwin S. Optimizing outcomes in depression: focus on antidepressant compliance. Int. Clin. Psychopharmacol. 17, 265-271 (2002).
7. Steimer W, Muller B, Leucht S, Kissling W. Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy. Clin. Chim. Acta 308, 33-41 (2001).
8. McIntyre IM, King CV, Skafdis S, Drummer OH. Dual UV wavelength high-performance liquid chromatographic method for the forensic or clinical ana lysis of seventeen antidepressants and some selected metabolites. J. Chromatogr. 621, 215-223 (1993).
9. Joron S, Robert H. Simultaneous determination of antidepressant drugs and metabolites by HPLC. Design and validation of a simple and reliable analytical procedure. Biomed. Chromatogr. 8, 158-164 (1994).
10. Aymard G, Livi P, Pham YT, Diquet B. Sensitive and rapid method for the simultaneous quantifcation of fve antidepressants with their respective metabolites in plasma using high-performance liquid chromatography with diode-array detection. J. Chromatogr. B. 700, 183-189 (1997).
11. Peterson KL, Logan BK, Christian GD, Ruzicka J. Sequential-injection extraction for sample preparation. Anal. Chim. Acta 337, 99-106 (1997).
12. Spratt E, Vallaro GM. LC/MS with a particle beam interface in forensic toxicology. Clin. Lab. Med. 18, 651-663 (1998).
13. Grønhaug T, Christensen H, Nordbø K, Johnsen E, Krogh M. Automated on-line dialysis, trace enrichment and high-performance liquid chromatography (HPLC) determination of two selective serotonin re-uptake inhibitors (SSRI) in plasma. J. Pharm. Belg. 53, 192 (1998).
14. Casamenti G, Mandrioli R, Sabbioni C, Bugamelli F, Volterra V, Raggi MA. Development of an HPLC method for the toxicological screening of central nervous system drugs. J. Liq. Chromatogr. Rel. Technol. 23, 1039-1059 (2000).
15. Skibinski R, Misztal G, Olajossy M. High performance liquid chromatographic determination of fuvoxamine and PAR in plasma. Chem. Anal. Warsaw 45, 815-823 (2000).
16. Lucca A, Gentilini G, Lopez-Silva S, Soldarini A. Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors by high-performance liquid chromatography. Ther. Drug Monit. 22, 271-276, (2000).
17. Lacassie E, Gaulier JM, Marquet P, Rabatel JF, Lachatre G. Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and GC. J. Chromatogr. B Biomed. Sci. Appl. 742, 229-238 (2000).
18. Tournel G, Houdret N, Hedouin V, Deveaux M, Gosset D, Lhermitte M. High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum. J. Chromatogr. B Biomed. Sci. Appl. 761, 147-158 (2001).
19. Oztunc A, Onal A, Erturk S. 7, 7, 8, 8-Tetracyanoquinodimethane as a new derivatization reagent for high-performance liquid chromatography and thin-layer chromatography: rapid screening of plasma for some antidepressants. J. Chromatogr. B Biomed. Sci. Appl. 774, 149-155 (2002).
20. Waschgler R, Hubmann MR, Conca A, Moll W, Konig P. Simultaneous quantifcation of citalopram, clozapine, FLU, norFLU, maprotiline, desmethylmaprotiline and trazodone in human serum by HPLC ana lysis. Int. J. Clin. Pharmacol. Ther. 40, 554-559 (2002).
21. Chen Y, Xiao H, Wu RJ. Simultaneous determination of PAR and sertraline in human plasma by RP-HPLC. J. China Pharm. Univ. 34, 141-143 (2003).
22. Frahnert C, Rao ML, Grasmader K. Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 794, 35-47 (2003).
23. Duverneuil C, De la Grandmaison GL, De Mazancourt P, Alvarez JC. A high-performance liquid chromatography method with photodiode-array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs. Ther. Drug Monit. 25, 565-573 (2003).
24. Goeringer KE, McIntyre IM, Drummer OH. LC-MS ana lysis of serotonergic drugs. J. Anal. Toxicol. 27, 30-35 (2003).
25. Kollroser M, Schober C. An online SPE-liquid chromatography-tandem MS method for the ana lysis of citalopram, fuvoxamine, and PAR in human plasma. Chromatographia 57, 133-138 (2003).
26. Hostetter AL, Stowe ZN, Cox M, Ritchie JC. A novel system for the determination of antidepressant concentrations in human breast milk. Ther. Drug Monit. 26, 47-52 (2004).
27. Wille SMR, Maudens KE, Van Peteghem CH, Lambert WEE. Development of a SPE for 13 'new' generation antidepressants and their active metabolites for gas chromatographic-mass spectrometric ana lysis. J. Chromatogr. A. 1098, 19-29 (2005).
28. Juan H, Zhiling Z, Huande L. Simultaneous determination of FLU, citalopram, PAR, VEN in plasma by HPLC-electrospray ionization MS (HPLC-MS/ESI). J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 820, 33-39 (2005).
29. Smyth WF, Leslie JC, McClean S et al. The characterization of selected antidepressant drugs using electrospray ionization with ion trap MS and with quadrupole time-of-fight MS and their determination by high-performance liquid chromatography/electrospray ionization tandem MS. Rapid Commun Mass Spectrom. 20, 1637-1642 (2006).
30. Kirchherr H, Kuhn-Velten WN. Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem MS: a multi-level, single-sample approach. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 843, 100-113 (2006).
31. Malfara WR, Bertucci C, Costa Queiroz ME et al. Reliable HPLC method for therapeutic drug monitoring of frequently prescribed tricyclic and nontricyclic antidepressants. J. Pharm. Biomed. Anal. 44, 955-962 (2007).
32. Silva BJG, Queiro RHC, Queiroz MEC. Simultaneous determination of nontricyclic antidepressants in human plasma by solid-phase microextraction and liquid chromatography (SPME-LC). J. Anal. Toxicol. 31, 313-320 (2007).
33. Walles M, Gauvin C, Morin PE, Panetta R, Ducharme J. Comparison of sub-2-microm particle columns for fast metabolite ID. J. Sep. Sci. 30, 1191-1199 (2007).
34. Unceta N, Gomez-Caballero A, Sanchez A et al. Simultaneous determination of citalopram, FLU and their main metabolites in human urine samples by solid-phase microextraction coupled with high-performance liquid chromatography. J. Pharm. Biomed. Anal. 46, 763-770 (2008).
35. Silva BJG, Lancas FM, Queiroz MEC. In-tube solid-phase microextraction coupled to liquid chromatography (in-tube SPME-LC) analysis of nontricyclic antidepressants in human plasma. J. Chromatogr. B. 862, 181-188 (2008).
36. Cruz-Vera M, Lucena R, Cardenas S, Valcarcel M. Combined use of carbon nanotubes and ionic liquid to improve the determination of antidepressants in urine samples by liquid chromatography. Anal. Bioanal. Chem. 391, 1139-1145 (2008).
37. Kristoffersen L, Bugge A, Lundanes E, Slordal L. Simultaneous determination of citalopram, FLU, PAR and their metabolites in plasma and whole blood by high-performance liquid chromatography with UV and fuorescence detection. J. Chromatogr. B. Biomed. Sci. Appl. 734(2), 229-246 (1999).
38. Titier K, Castaing N, Scotto-Gomez E, Pehourcq F, Moore N, Molimard M. High-performance liquid chromatographic method with DAD for identifcation and quantifcation of the eight new antidepressants and fve of their active metabolites in plasma after overdose. Ther. Drug Monit. 25(5), 581-587 (2003).
39. Lacassie E, Ragot S, Gaulier JM, Marquet P, Lachatre G. A specifc analytical method for the ana lysis of 24 antidepressants using GC-MS (GC/MS). Acta Clin Belg. 54, 20-24 (1999).
40. Maurer HH, Bickeboeller-Friedrich J. Screening procedure for detection of antidepressants of the selective serotonin reuptake inhibitor type and their metabolites in urine as part of a modifed systematic toxicological ana lysis procedure using GC-MS. J. Anal. Toxicol. 24, 340-347 (2000).
41. Bickeboeller-Friedrich J, Maurer HH. Screening for detection of new antidepressants, neuroleptics, hypnotics, and their metabolites in urine by GC-MS developed using rat liver microsomes. Ther. Drug Monit. 23, 61-70 (2001).
42. Martinez MA, Sanchez de la Torre C, Almarza E. Simultaneous determination of viloxazine, VEN, imipramine, desipramine, sertraline, and amoxapine in whole blood: comparison of two extraction/cleanup procedures for capillary GC with nitrogen-phosphorus detection. J. Anal. Toxicol. 26, 296-302 (2002).
43. Martinez MA, Sanchez de la Torre C, Almarza E. A comparative solid-phase extraction study for the simultaneous determination of FLU, amitriptyline, nortriptyline, trimipramine, maprotiline, clomipramine, and trazodone in whole blood by capillary gas-liquid chromatography with nitrogen-phosphorus detection. J. Anal. Toxicol. 27, 353-358 (2003).
44. Gunnar T, Mykkanen S, Ariniemi K, Lillsunde P. Validated semiquantitative/quantitative screening of 51 drugs in whole blood as silylated derivatives by GC-selected ion monitoring MS and GC electron capture detection. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 806, 205-219 (2004).
45. Paterson S, Cordero R, Burlinson S. Screening and semi-quantitative ana lysis of post mortem blood for basic drugs using GC/ion trap MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 813, 323-330 (2004).
46. Wylie FM, Torrance H, Anderson RA, Oliver JS. Drugs in oral fuid Part I. Validation of an analytical procedure for licit and illicit drugs in oral fuid. Forensic Sci. Int. 150, 191-198 (2005).
47. Salgado-Petinal C, Lamas JP, Garcia-Jares C, Llompart M, Cela R. Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction GC-MS. Anal. Bioanal. Chem. 382, 1351-1359 (2005).
48. Nevado JJB, Llerena MJV, Cabanillas CG, Robledo VR. Screening of citalopram, FLU and their metabolites in human urine samples by GC-MS A global robustness/ruggedness study. J. Chromatogr. A. 1123, 130-133 (2006).
49. Stankova M, Ondra P, Kurka P. The possibilities of diagnostics in antidepressant intoxications. Chemicke Listy 101, 916-922 (2007).
50. Wille SMR, Van Hee P, Neels HM, Van Peteghem CH, Lambert WE. Comparison of electron and chemical ionization modes by validation of a quantitative gas chromatographic-mass spectrometric assay of new generation antidepressants and their active metabolites in plasma. J. Chromatogr. A. 1176, 236-245 (2007).
51. Bjørhovde A, Halvorsen TG, Rasmussen KE, Pedersen-Bjergaard S. Liquid-phase microextraction of drugs from human breast milk. Anal. Chim. Acta 491, 155-161 (2003).
52. Misztal G, Hopkala H, Slawik T. Chromatographic ana lysis (TLC) of FLU, doxepine, imipramine and opipramol in human plasma. Acta Pol. Pharm. 54, 257-259 (1997).
53. Gondova T, Halamova D, Spacayova K. Simultaneous ana lysis of new antidepressants by densitometric thin-layer chromatography. J. Liq. Chromatogr. Rel. Technol. 31, 2429-2441 (2008).